Pet Parasite Prevention and Control Drugs Market Insights, Global Outlook and Forecast 2022-2028
The study offers detailed insights on market size and forecasts of Pet Parasite Prevention and Control Drugs in global, including the following market information:
Global Pet Parasite Prevention and Control Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pet Parasite Prevention and Control Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pet Parasite Prevention and Control Drugs companies in 2021 (%)
The global Pet Parasite Prevention and Control Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pet Parasite Prevention and Control Drugs include Boehringer Ingelheim, Bayer, Zoetis, Dechra Pharmaceuticals, Chanelle Pharma, Merck Animal Health, Elanco, Virbac and Vetoquinol. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market IntelliX study on the Pet Parasite Prevention and Control Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Key Segments of Market
Global Pet Parasite Prevention and Control Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pet Parasite Prevention and Control Drugs Market Segment Percentages, by Type, 2021 (%)
Topical Medication
Injection Medication
Oral Medication
Global Pet Parasite Prevention and Control Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pet Parasite Prevention and Control Drugs Market Segment Percentages, by Application, 2021 (%)
Dog
Cat
Others
Global Pet Parasite Prevention and Control Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pet Parasite Prevention and Control Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Parasite Prevention and Control Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pet Parasite Prevention and Control Drugs revenues share in global market, 2021 (%)
Key companies Pet Parasite Prevention and Control Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pet Parasite Prevention and Control Drugs sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Boehringer Ingelheim
Bayer
Zoetis
Dechra Pharmaceuticals
Chanelle Pharma
Merck Animal Health
Elanco
Virbac
Vetoquinol
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
Why should you invest in our reports
The reports drafted by our industry analysts are credible and have been researched and validated from several primary and secondary resources. What makes us unique is the fact that along with presenting an analysis of the market’s historical and present scenario, we also present a forecast review of the market for the benefit of our readers. The presentation is exclusive in the form of various charts, tables, and diagrams. Every bit of information present in the market research report is unique. Expert estimations are also present in the study that can be directly used by the readers to make future decisions.
1 Introduction to Research & Analysis Reports
1.1 Pet Parasite Prevention and Control Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Parasite Prevention and Control Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pet Parasite Prevention and Control Drugs Overall Market Size
2.1 Global Pet Parasite Prevention and Control Drugs Market Size: 2021 VS 2028
2.2 Global Pet Parasite Prevention and Control Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pet Parasite Prevention and Control Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Pet Parasite Prevention and Control Drugs Players in Global Market
3.2 Top Global Pet Parasite Prevention and Control Drugs Companies Ranked by Revenue
3.3 Global Pet Parasite Prevention and Control Drugs Revenue by Companies
3.4 Global Pet Parasite Prevention and Control Drugs Sales by Companies
3.5 Global Pet Parasite Prevention and Control Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pet Parasite Prevention and Control Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pet Parasite Prevention and Control Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pet Parasite Prevention and Control Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pet Parasite Prevention and Control Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pet Parasite Prevention and Control Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pet Parasite Prevention and Control Drugs Market Size Markets, 2021 & 2028
4.1.2 Topical Medication
4.1.3 Injection Medication
4.1.4 Oral Medication
4.2 By Type - Global Pet Parasite Prevention and Control Drugs Revenue & Forecasts
4.2.1 By Type - Global Pet Parasite Prevention and Control Drugs Revenue, 2017-2022
4.2.2 By Type - Global Pet Parasite Prevention and Control Drugs Revenue, 2023-2028
4.2.3 By Type - Global Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Pet Parasite Prevention and Control Drugs Sales & Forecasts
4.3.1 By Type - Global Pet Parasite Prevention and Control Drugs Sales, 2017-2022
4.3.2 By Type - Global Pet Parasite Prevention and Control Drugs Sales, 2023-2028
4.3.3 By Type - Global Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Pet Parasite Prevention and Control Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Pet Parasite Prevention and Control Drugs Market Size, 2021 & 2028
5.1.2 Dog
5.1.3 Cat
5.1.4 Others
5.2 By Application - Global Pet Parasite Prevention and Control Drugs Revenue & Forecasts
5.2.1 By Application - Global Pet Parasite Prevention and Control Drugs Revenue, 2017-2022
5.2.2 By Application - Global Pet Parasite Prevention and Control Drugs Revenue, 2023-2028
5.2.3 By Application - Global Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Pet Parasite Prevention and Control Drugs Sales & Forecasts
5.3.1 By Application - Global Pet Parasite Prevention and Control Drugs Sales, 2017-2022
5.3.2 By Application - Global Pet Parasite Prevention and Control Drugs Sales, 2023-2028
5.3.3 By Application - Global Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Pet Parasite Prevention and Control Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Pet Parasite Prevention and Control Drugs Market Size, 2021 & 2028
6.2 By Region - Global Pet Parasite Prevention and Control Drugs Revenue & Forecasts
6.2.1 By Region - Global Pet Parasite Prevention and Control Drugs Revenue, 2017-2022
6.2.2 By Region - Global Pet Parasite Prevention and Control Drugs Revenue, 2023-2028
6.2.3 By Region - Global Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Pet Parasite Prevention and Control Drugs Sales & Forecasts
6.3.1 By Region - Global Pet Parasite Prevention and Control Drugs Sales, 2017-2022
6.3.2 By Region - Global Pet Parasite Prevention and Control Drugs Sales, 2023-2028
6.3.3 By Region - Global Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pet Parasite Prevention and Control Drugs Revenue, 2017-2028
6.4.2 By Country - North America Pet Parasite Prevention and Control Drugs Sales, 2017-2028
6.4.3 US Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.4.4 Canada Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.4.5 Mexico Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pet Parasite Prevention and Control Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Pet Parasite Prevention and Control Drugs Sales, 2017-2028
6.5.3 Germany Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.5.4 France Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.5.5 U.K. Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.5.6 Italy Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.5.7 Russia Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.5.9 Benelux Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pet Parasite Prevention and Control Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Pet Parasite Prevention and Control Drugs Sales, 2017-2028
6.6.3 China Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.6.4 Japan Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.6.5 South Korea Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.6.7 India Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pet Parasite Prevention and Control Drugs Revenue, 2017-2028
6.7.2 By Country - South America Pet Parasite Prevention and Control Drugs Sales, 2017-2028
6.7.3 Brazil Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.7.4 Argentina Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pet Parasite Prevention and Control Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pet Parasite Prevention and Control Drugs Sales, 2017-2028
6.8.3 Turkey Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.8.4 Israel Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
6.8.6 UAE Pet Parasite Prevention and Control Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporate Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Major Product Offerings
7.1.4 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Boehringer Ingelheim Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Pet Parasite Prevention and Control Drugs Major Product Offerings
7.2.4 Bayer Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Bayer Key News
7.3 Zoetis
7.3.1 Zoetis Corporate Summary
7.3.2 Zoetis Business Overview
7.3.3 Zoetis Pet Parasite Prevention and Control Drugs Major Product Offerings
7.3.4 Zoetis Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Zoetis Key News
7.4 Dechra Pharmaceuticals
7.4.1 Dechra Pharmaceuticals Corporate Summary
7.4.2 Dechra Pharmaceuticals Business Overview
7.4.3 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Major Product Offerings
7.4.4 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Dechra Pharmaceuticals Key News
7.5 Chanelle Pharma
7.5.1 Chanelle Pharma Corporate Summary
7.5.2 Chanelle Pharma Business Overview
7.5.3 Chanelle Pharma Pet Parasite Prevention and Control Drugs Major Product Offerings
7.5.4 Chanelle Pharma Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Chanelle Pharma Key News
7.6 Merck Animal Health
7.6.1 Merck Animal Health Corporate Summary
7.6.2 Merck Animal Health Business Overview
7.6.3 Merck Animal Health Pet Parasite Prevention and Control Drugs Major Product Offerings
7.6.4 Merck Animal Health Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Merck Animal Health Key News
7.7 Elanco
7.7.1 Elanco Corporate Summary
7.7.2 Elanco Business Overview
7.7.3 Elanco Pet Parasite Prevention and Control Drugs Major Product Offerings
7.7.4 Elanco Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Elanco Key News
7.8 Virbac
7.8.1 Virbac Corporate Summary
7.8.2 Virbac Business Overview
7.8.3 Virbac Pet Parasite Prevention and Control Drugs Major Product Offerings
7.8.4 Virbac Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Virbac Key News
7.9 Vetoquinol
7.9.1 Vetoquinol Corporate Summary
7.9.2 Vetoquinol Business Overview
7.9.3 Vetoquinol Pet Parasite Prevention and Control Drugs Major Product Offerings
7.9.4 Vetoquinol Pet Parasite Prevention and Control Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Vetoquinol Key News
8 Global Pet Parasite Prevention and Control Drugs Production Capacity, Analysis
8.1 Global Pet Parasite Prevention and Control Drugs Production Capacity, 2017-2028
8.2 Pet Parasite Prevention and Control Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pet Parasite Prevention and Control Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pet Parasite Prevention and Control Drugs Supply Chain Analysis
10.1 Pet Parasite Prevention and Control Drugs Industry Value Chain
10.2 Pet Parasite Prevention and Control Drugs Upstream Market
10.3 Pet Parasite Prevention and Control Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pet Parasite Prevention and Control Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Pet Parasite Prevention and Control Drugs in Global Market
Table 2. Top Pet Parasite Prevention and Control Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pet Parasite Prevention and Control Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pet Parasite Prevention and Control Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Pet Parasite Prevention and Control Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Pet Parasite Prevention and Control Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pet Parasite Prevention and Control Drugs Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pet Parasite Prevention and Control Drugs Product Type
Table 9. List of Global Tier 1 Pet Parasite Prevention and Control Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Parasite Prevention and Control Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pet Parasite Prevention and Control Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pet Parasite Prevention and Control Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pet Parasite Prevention and Control Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Pet Parasite Prevention and Control Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pet Parasite Prevention and Control Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pet Parasite Prevention and Control Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pet Parasite Prevention and Control Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Pet Parasite Prevention and Control Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pet Parasite Prevention and Control Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pet Parasite Prevention and Control Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pet Parasite Prevention and Control Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Pet Parasite Prevention and Control Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pet Parasite Prevention and Control Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Pet Parasite Prevention and Control Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pet Parasite Prevention and Control Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Pet Parasite Prevention and Control Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pet Parasite Prevention and Control Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Pet Parasite Prevention and Control Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pet Parasite Prevention and Control Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Pet Parasite Prevention and Control Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pet Parasite Prevention and Control Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Pet Parasite Prevention and Control Drugs Sales, (K Units), 2023-2028
Table 46. Boehringer Ingelheim Corporate Summary
Table 47. Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Product Offerings
Table 48. Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Bayer Corporate Summary
Table 50. Bayer Pet Parasite Prevention and Control Drugs Product Offerings
Table 51. Bayer Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Zoetis Corporate Summary
Table 53. Zoetis Pet Parasite Prevention and Control Drugs Product Offerings
Table 54. Zoetis Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Dechra Pharmaceuticals Corporate Summary
Table 56. Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Product Offerings
Table 57. Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Chanelle Pharma Corporate Summary
Table 59. Chanelle Pharma Pet Parasite Prevention and Control Drugs Product Offerings
Table 60. Chanelle Pharma Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Merck Animal Health Corporate Summary
Table 62. Merck Animal Health Pet Parasite Prevention and Control Drugs Product Offerings
Table 63. Merck Animal Health Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Elanco Corporate Summary
Table 65. Elanco Pet Parasite Prevention and Control Drugs Product Offerings
Table 66. Elanco Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Virbac Corporate Summary
Table 68. Virbac Pet Parasite Prevention and Control Drugs Product Offerings
Table 69. Virbac Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Vetoquinol Corporate Summary
Table 71. Vetoquinol Pet Parasite Prevention and Control Drugs Product Offerings
Table 72. Vetoquinol Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Pet Parasite Prevention and Control Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Pet Parasite Prevention and Control Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Pet Parasite Prevention and Control Drugs Production by Region, 2017-2022 (K Units)
Table 76. Global Pet Parasite Prevention and Control Drugs Production by Region, 2023-2028 (K Units)
Table 77. Pet Parasite Prevention and Control Drugs Market Opportunities & Trends in Global Market
Table 78. Pet Parasite Prevention and Control Drugs Market Drivers in Global Market
Table 79. Pet Parasite Prevention and Control Drugs Market Restraints in Global Market
Table 80. Pet Parasite Prevention and Control Drugs Raw Materials
Table 81. Pet Parasite Prevention and Control Drugs Raw Materials Suppliers in Global Market
Table 82. Typical Pet Parasite Prevention and Control Drugs Downstream
Table 83. Pet Parasite Prevention and Control Drugs Downstream Clients in Global Market
Table 84. Pet Parasite Prevention and Control Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pet Parasite Prevention and Control Drugs Segment by Type
Figure 2. Pet Parasite Prevention and Control Drugs Segment by Application
Figure 3. Global Pet Parasite Prevention and Control Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pet Parasite Prevention and Control Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pet Parasite Prevention and Control Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Pet Parasite Prevention and Control Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pet Parasite Prevention and Control Drugs Revenue in 2021
Figure 9. By Type - Global Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pet Parasite Prevention and Control Drugs Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pet Parasite Prevention and Control Drugs Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
Figure 19. US Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
Figure 24. Germany Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
Figure 33. China Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pet Parasite Prevention and Control Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pet Parasite Prevention and Control Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pet Parasite Prevention and Control Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pet Parasite Prevention and Control Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Pet Parasite Prevention and Control Drugs by Region, 2021 VS 2028
Figure 50. Pet Parasite Prevention and Control Drugs Industry Value Chain
Figure 51. Marketing Channels
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|